Effect of heparin-stimulated plasma lipolytic activity on VLDL APO B subclass metabolism in normal subjects

Atherosclerosis

Volumn 146, Issue 2, 1999, Pages 381-390

  Malmström, Raija ^a   Packard, Christopher J ^b   Caslake, Muriel ^b   Bedford, Dorothy ^b   Stewart, Philip ^b   Shepherd, James ^b   Taskinen, Marja Riitta ^a  

^a Department of Medicine   (Finland)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Apolipoprotein B; Free fatty acid; Kinetics; Stable isotopes; Triglyceride

Indexed keywords

APOLIPOPROTEIN B; FATTY ACID; HEPARIN; LEUCINE; LIPOPROTEIN; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; TRITIUM;

ADULT; ARTICLE; CATABOLISM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; LIPOLYSIS; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTICOAGULANTS; APOLIPOPROTEINS B; BLOOD GLUCOSE; CHOLESTEROL, VLDL; FATTY ACIDS, NONESTERIFIED; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HEPARIN; HUMANS; INSULIN; LIPASE; LIPOLYSIS; LIPOPROTEIN LIPASE; LIVER; MALE; MIDDLE AGED; REFERENCE VALUES;

EID: 0032845316     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00153-7     Document Type: Article

References (42)

1. Hahn P.F. Abolishment of alimentary lipemia following injection of heparin. Science. 98:1943;19-20.
2. Olivecrona T., Bengtsson-Olivecrona G. Lipoprotein lipase and hepatic lipase. Curr Opin Lipidol. 1:1990;222-230.
3. Gaw A., Packard C.J., Lindsay G.M., Griffin B.A., Caslake M.J., Lorimer A.R., Shepherd J. Overproduction of small very low density lipoproteins (Sf 20-60) in moderate hypercholesterolemia: Relationship between apolipoprotein B kinetics and plasma lipoproteins. J Lipid Res. 36:1995;158-171.
4. Malmström R., Packard C.J., Watson T.D.G., Rannikko S., Caslake M., Bedford D., Stewart P., Yki-Järvinen H., Shepherd J., Taskinen M.-R. Metabolic basis of hypotriglyceridemic effects of insulin in normal men. Arterioscler Thromb Vasc Biol. 17:1997;1454-1464.
5. Björkegren J., Packard C.J., Hamsten A., Bedford D., Caslake M., Foster L., Shepherd J., Stewart P., Karpe F. Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway. J Lipid Res. 37:1996;76-86.
6. Weintraub M., Rassin T., Eisenberg S., Ringel Y., Grosskopf I., Iaina A., Charach G., Liron M., Rubinstein A. Continuous intravenous heparin administration in humans causes a decrease in serum lipolytic activity and accumulation of chylomicrons in circulation. J Lipid Res. 35:1994;229-238.
7. Patsch J.R., Miesenböck G., Hopferwieser T., Muhlberger V., Knapp E., Dunn J.K., Gotto Jr A.M., Patsch W. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb. 12:1992;1336-1345.
8. Lewis G.F., Uffelman K.D., Szeto L.W., Weller B., Steiner G. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest. 95:1995;158-166.
9. Byrne C.D., Brindle N.P.J., Wang T.W.M., Hales C.N. Interaction of non-esterified fatty acid and insulin in control of triacylglycerol secretion by Hep G2 cells. Biochem J. 280:1991;99-104.
10. Dashti N., Williams D.L., Alaupovic P. Effects of oleate and insulin on the production rates and cellular mRNA concentrations of apolipoproteins in HepG2 cells. J Lipid Res. 30:1989;1365-1373.
11. Lang C.A., Davis R.A. Fish oil fatty acids impair VLDL assembly and/or secretion by cultured rat hepatocytes. J Lipid Res. 31:1990;2079-2086.
12. Ellsworth J.L., Erickson S.K., Cooper A.D. Very low and low density lipoprotein synthesis and secretion by the human hepatoma cell line Hep-G2: effects of free fatty acids. J Lipid Res. 27:1986;858-874.
13. Boström K., Boren J., Wettesten M., Sjöberg A., Bondjers G., Wiklund O., Carlsson P., Olofsson S. Studies on the assembly of apo-B-100-containing lipoproteins in HepG2 cells. J Biol Chem. 263:1988;4434-4442.
14. Pullinger C.R., North J.D., Teng B., Rifici V.A., deBrito A.E.R., Scott J. The apolipoprotein B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin and insulin and measurement of the mRNA half-life. J Lipid Res. 30:1989;1065-1077.
15. Diabetes mellitus. Report of WHO Study Group. In: WHO technical report series. 1985;World Health Organization, Geneva.
16. Lindgren F.T., Jensen L.C. The isolation and quantitative analysis of serum lipoproteins. Nelson G.J. Blood Lipids and Lipoproteins: Quantitation, Composition and Metabolism. 1972;182-217 Wiley, Livermore, CA.
17. James R.W., Martin B., Pometta D., Fruchart J.C., Duriez P., Puchois P., Farriaux J.P., Tacquet A., Demant T., Clegg R.J., Munro A., Oliver M.F., Packard C.J., Shepherd J. Apolipoprotein B metabolism in homozygous familial hypercholesterolemia. J Lipid Res. 30:1989;159-169.
18. Yang C., Chen S., Gianturco S.H., Bradley W.A., Sparrow J.T., Tanimura M., Li W., Sparrow D.A., DeLoof H., Rosseneu M., Lee F., Gu Z., Gotto Jr A.M., Chan L. Sequence, structure, receptor-binding domains and internal repeats of human apolipoprotein B-100. Nature. 323:1986;738-742.
19. Egusa G., Brady D.W., Grundy S.M., Howard B.V. Isopropanol precipitation method for the determination of apolipoprotein B specific activity and plasma concentrations during metabolic studies of very low density lipoprotein and low density lipoprotein apolipoprotein B. J Lipid Res. 24:1983;1261-1267.
20. Demant T., Packard C.J., Demmelmair H., Stewart P., Bedynek A., Bedford D., Seidel D., Shepherd J. Sensitive methods to study human apolipoprotein B metabolism using stable isotope labelled amino acids. Am J Physiol. 270:1996;E1022-E1036.
21. Anon SAAM II. SAAM II User Guide. SAAM Institute. 1997;1997 University of Washington, Seattle, WA.
22. Malmström R., Packard C.J., Caslake M., Bedford D., Stewart P., Yki-Järvinen H., Shepherd J., Taskinen M.-R. Defective regulation of triglyceride metabolism by insulin in the liver in non-insulin-dependent diabetes mellitus. Diabetologia. 40:1997;454-462.
23. Malmström R., Packard C.J., Caslake M., Bedford D., Stewart P., Yki-Järvinen H., Taskinen M. Effects of insulin and acipimox on VLDL1 and VLDL2 apo B production in normal subjects. Diabetes. 47:1998;779-787.
24. Kadish A.H., Litle R.L., Sternberg J.C. A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem. 14:1968;116-131.
25. Miles J., Glasscock R., Aikens J., Gerich J., Haymond M. A microfluorometric method for the determination of free fatty acids in plasma. J Lipid Res. 24:1983;96-99.
26. Roberts I., Smith I.M. A simple method for the measurement of glycerol in serum. Ann Clin Biochem. 23:1986;490-491.
27. Kashyap M.L., Hynd B.A., Robinson K. A rapid and simple method for measurement of total protein in very low density lipoproteins by the Lowry assay. J Lipid Res. 21:1980;491-495.
28. Huttunen J.K., Ehnholm C., Kinnunen P., Nikkilä E.A. An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma. Clin Chim Acta. 63:1975;335-347.
29. Taskinen M.-R., Packard C.J., Shepherd J. Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM. Diabetes. 39:1990;1017-1027.
30. Rising R., Swinburn B., Larson K., Ravussin E. Body composition in Pima Indians: validation of bioelectrical resistance. Am J Clin Nutr. 53:1991;594-598.
31. Argraves K.M., Battey F.D., MacCalman C.D., Gafvels M.K.R.M., Kozarsky K.F., Chappell D.A., StraussIII J.F., Strickland D.K. The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes. J Biol Chem. 270:1995;26550-26557.
32. Beisiegel U., Weber W., Bengtsson-Olivecrona G. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc Natl Acad Sci USA. 88:1991;8342-8346.
33. Zambon A., Schmidt I., Beisiegel U., Brunzell J.D. Dimeric lipoprotein lipase is bound to triglyceride-rich plasma lipoproteins. J Lipid Res. 37:1996;2394-2404.
34. Wu X., Sakata N., Dixon J., Ginsberg H.N. Exogenous VLDL stimulates apolipoprotein B secretion from HepG2 cells by both pre- and post-translational mechanisms. J. Lipid Res. 35:1994;1200-1210.
35. Graig W.Y., Cooper A.D. Effects of chylomicron remnants and b-VLDL on the class and composition of newly secreted lipoproteins by HepG2 cells. J. Lipid Res. 29:1988;299-308.
36. Demant T., Bedford D., Packard G.J., Sheperd J. Influence of apolipoprotein E polymorphism on lipoprotein B-100 metabolism in normolipemic subjects. J. Clin. Invest. 88:1991;1490-1501.
37. Heimberg M., Weinstein I., Dishmon G., Dunkerley A. The action of carbon tetrachloride on the transport and metabolism of triglycerides and fatty acids by the isolated perfused rat liver and its relationship to the etiology of fatty liver. J Biol Chem. 37:1962;3623-3627.
38. Gibbons G.F., Bartlett S.M., Sparks C.E., Sparks J.D. Extracellular fatty acids are not utilized directly for the synthesis of very-low-density lipoprotein in primary cultures of rat hepatocytes. Biochem J. 287:1992;749-753.
39. Salam W.H., Wilcox H.G., Heimberg M. Effects of oleic acid on the biosynthesis of lipoprotein apoproteins and distribution into the very-low-density lipoprotein by the isolated perfused rat liver. Biochem J. 251:1988;809-816.
40. Steiner G., Haynes F.J., Yoshino G., Vranic M. Hyperinsulinemia and in vivo very-low-density lipoprotein-triglyceride kinetics. Am J Physiol. 246:1984;E187-E192.
41. Duerden J.M., Bartlett S.M., Gibbons G.F. Long-term maintenance of high rates of very-low-density-lipoprotein secretion in hepatocyte cultures. Biochem J. 263:1989;937-943.
42. Bartlett S.M., Gibbons G.F. Short- and long-term regulation of very-low-density lipoprotein secretion by insulin, dexamethasone and lipogenic substrates in cultured hepatocytes. A biphasic effect of insulin. Biochem J. 249:1988;37-43.